Valeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher

Valeant Pharmaceuticals International, Inc. VRX was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.06 to $14.94 in the past one-month time frame.

The stock gained after the company reported that Joseph C. Papa, chairman and chief executive officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Stifel 2017 Healthcare Conference in New York on Nov. 14, 2017.

The company has seen a mixed track record when it comes to estimate revisions of four increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Valeant Pharmaceuticalscurrently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Valeant Pharmaceuticals International, Inc. Price

Valeant Pharmaceuticals International, Inc. Price | Valeant Pharmaceuticals International, Inc. Quote

A better-ranked stock in the Medical sector is Advanced Accelerator Applications S.A. AAAP, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is VRX going up? Or down? Predict to see what others think: Up or Down.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Valeant Pharmaceuticals International, Inc. (VRX) : Free Stock Analysis Report
 
Advanced Accelerator Applications S.A. (AAAP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.